Envomed 80 wins prestigious Climate Solutions Prize
Our Envomed 80 On-site Medical Waste Treatment Solution has won Takeda’s Addressing Plastic Waste in the Plasma Industry Challenge.
The prestigious Climate Solutions Prize, awarded by the Startup Nation Central together with Climate Solutions Prize Organization, was presented to Envomed for “a unique machine that shreds and sterilizes medical waste simultaneously using a scientifically developed and proven chemical sterilization technology that can achieve a 6-log reduction of spores in infectious medical waste”.
A total of $1.3 million (US) was awarded to Israeli climate tech startups as part of the startup track of the Climate Solutions Prize (CSP) at the event in TEL AVIV, Israel on 26 February 2024.
The CSP is an initiative that was established to address the global climate crisis and incentivize climate innovation. The startup track, in which Envomed participated, was led by Startup Nation Central together with Climate Solutions Prize Organization.
The Takeda Challenge, won by Envomed, was created to highlight solutions that reduce single-use plastic waste, including both medical waste and non-hazardous waste.
Envomed CEO Hagai Yehidi commented: “I would like to thank the Envomed team whose hard work and dedication to developing such an important solution has received this richly deserved recognition. I would also like to thank the team at SNC Startup Nation Central for managing this great mission and, of course, our friends and new partners in Takeda for placing their trust in our innovative technology.”
“This award represents Envomed’s commitment to tackling the world’s medical waste treatment problem using the innovation and excellence we have become known for”.
In a subsequent news release Startup Nation Central’s CEO, Avi Hasson commented on the importance of the initiative: “As a recognized leader in developing advanced solutions to global challenges, Israel is extremely well-positioned to take a central role in battling climate change and bringing solutions to the biggest shared challenge of our times. The initiative, designed to award the best and brightest climate tech startups throughout Israel, provides access to investment, partnership opportunities with global MNCs, and exposure at COP28 to global solution seekers, to promote scalable, sustainable solutions to pressing environmental challenges”.
About the Envomed80
The Envomed80 is a scientifically driven, onsite solution for Medical and Infectious Waste treatment. Totally unique in the market today, the Envomed80 shreds and sterilizes medical waste simultaneously, using a scientifically developed and proven technology which has the ability to sterilize medical waste to STAATT level IV. Offering an extremely powerful & environmentally friendly solution, the Envomed80 can treat 80 litres of infectious and sharps medical waste in under 20 minutes.
Environmentally friendly, the Envomed80 has a lower carbon footprint than alternative treatment solutions on the market today. It was developed by Maabarot Metal Works Ltd, a company with extensive technical knowledge and over 30 years’ experience in providing specialized industrial machinery.
Identifying the market’s need for efficient on-site medical waste treatment facilities, MMW made significant investments in R&D and engineered a solution that is revolutionary from economic, safety and environmental perspectives.
A non-compromise game changing solution, The Envomed80 unit offers fully comprehensive validation using both the solid and liquid phases of real infectious waste, including the presence of protein, haemoglobin, carbohydrate, lipids and insoluble fibres.
Its sterilization process consistently demonstrates a 6 LOG10/ml bacterial spores’ reduction, which complies with STAATT level IV, according to the ISTAATT guidelines (both in the liquid and solid phases). Currently, the Envomed80 is the only on-site medical waste treatment technology approved by the Israeli Ministry of Health due to the above comprehensive validation requirements.